PHIO

#4754
Phio Pharmaceuticals Corp. Common Stock
1.2850 USD
-0.39%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
1.2850
1.2854
Yıllık Aralık
0.9780
1.3500
Günlük Değişim
-0.39%
Aylık Değişim
+6.20%
6 aylık değişim
+7.98%
Yıllık Değişim
+7.98%
Önceki Kapanış
1.2900
Open
1.2854
Bid
Ask
Low
1.2850
High
1.2854
Hacim
3
Open full chart

Financials

Overview Rapor Statistics
Quarterly Annual
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Haberler